Asensus Surgical, Inc.
ASXC
ASXC was delisted on the 21st of August, 2024.
79 hedge funds and large institutions have $17.5M invested in Asensus Surgical, Inc. in 2023 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 11 increasing their positions, 17 reducing their positions, and 10 closing their positions.
342% more call options, than puts
Call options by funds: $358K | Put options by funds: $81K
97% more capital invested
Capital invested by funds: $8.86M → $17.5M (+$8.61M)
60% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 10
7% more funds holding
Funds holding: 74 → 79 (+5)
35% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 17
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MCM
Masters Capital Management
Atlanta,
Georgia
|
+$1.25M |
| 2 |
AA
AlphaCentric Advisors
San Juan,
Puerto Rico
|
+$339K |
| 3 |
State Street
Boston,
Massachusetts
|
+$94.8K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$66.8K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$54.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$264K |
| 2 |
Millennium Management
New York
|
-$238K |
| 3 |
Morgan Stanley
New York
|
-$198K |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$148K |
| 5 |
E
Ergoteles
New York
|
-$76.3K |
ASXC Hedge Fund Activity: Q1 2023 in Review
79 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Asensus Surgical, Inc. (ASXC) for Q1 2023, worth a combined $17.5M — up 97% from $8.86M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new ASXC positions and 10 closed out — a net gain of 6 holders — while 11 added to existing stakes and 17 trimmed.
The largest buyer was Masters Capital Management, opening a new position worth an estimated $1.25M. The largest seller was Susquehanna International Group, cutting an estimated $264K.
- 79 institutional investors held Asensus Surgical, Inc. (ASXC) as of Q1 2023, up from 74 in Q4 2022.
- Funds reported $17.5M of Asensus Surgical, Inc. stock for Q1 2023, up 97% quarter-over-quarter.
- 16 funds opened new Asensus Surgical, Inc. positions in Q1 2023 and 10 closed out, a net change of +6 holders.
- The largest Asensus Surgical, Inc. buyer in Q1 2023 was Masters Capital Management, an estimated $1.25M added.
- The largest Asensus Surgical, Inc. seller in Q1 2023 was Susquehanna International Group, an estimated $264K sold.
Based on aggregated 13F filings for Q1 2023.